Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$13.88
-2.7%		$11.46
$6.26
▼
$15.89
$1.20B0.63843,413 shs716,213 shs
Haemonetics Corporation stock logo
HAE
Haemonetics
$89.98
-0.9%		$79.39
$47.31
▼
$92.25
$4.13B0.52755,338 shs467,920 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$125.13
-0.1%		$101.47
$62.00
▼
$126.14
$4.26B0.611.62 million shs429,992 shs
LivaNova PLC stock logo
LIVN
LivaNova
$81.48
-0.9%		$80.49
$48.82
▼
$85.76
$4.53B0.86706,720 shs445,064 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
0.00%+0.92%+18.24%+34.15%+93.49%
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%+3.84%+16.53%+58.68%+68.73%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%+0.22%+31.16%+39.11%+17.31%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%+7.87%+1.88%+13.83%+53.05%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$13.88
-2.7%		$11.46
$6.26
▼
$15.89
$1.20B0.63843,413 shs716,213 shs
Haemonetics Corporation stock logo
HAE
Haemonetics
$89.98
-0.9%		$79.39
$47.31
▼
$92.25
$4.13B0.52755,338 shs467,920 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$125.13
-0.1%		$101.47
$62.00
▼
$126.14
$4.26B0.611.62 million shs429,992 shs
LivaNova PLC stock logo
LIVN
LivaNova
$81.48
-0.9%		$80.49
$48.82
▼
$85.76
$4.53B0.86706,720 shs445,064 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
0.00%+0.92%+18.24%+34.15%+93.49%
Haemonetics Corporation stock logo
HAE
Haemonetics
0.00%+3.84%+16.53%+58.68%+68.73%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%+0.22%+31.16%+39.11%+17.31%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%+7.87%+1.88%+13.83%+53.05%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioventus Inc. stock logo
BVS
Bioventus
2.83
Moderate Buy$16.8021.04% Upside
Haemonetics Corporation stock logo
HAE
Haemonetics
2.73
Moderate Buy$90.891.01% Upside
Integer Holdings Corporation stock logo
ITGR
Integer
2.07
Hold$109.86-12.21% Downside
LivaNova PLC stock logo
LIVN
LivaNova
2.73
Moderate Buy$83.502.48% Upside

Current Analyst Ratings Breakdown

Latest BVS, LIVN, ITGR, and HAE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
Bioventus Inc. stock logo
BVS
Bioventus
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $19.00
8/17/2026
Bioventus Inc. stock logo
BVS
Bioventus
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$15.00
8/13/2026
Integer Holdings Corporation stock logo
ITGR
Integer
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
8/11/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$105.00
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$96.00
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Barrington Research logo
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$95.00
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$79.00 ➝ $92.00
8/7/2026
Haemonetics Corporation stock logo
HAE
Haemonetics
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$62.00 ➝ $86.00
8/6/2026
Bioventus Inc. stock logo
BVS
Bioventus
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
8/6/2026
Bioventus Inc. stock logo
BVS
Bioventus
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$18.00
(Data available from 8/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioventus Inc. stock logo
BVS
Bioventus
$581.85M2.01$1.24 per share11.18$2.76 per share5.03
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.33B3.07$7.51 per share11.98$17.14 per share5.25
Integer Holdings Corporation stock logo
ITGR
Integer
$1.84B2.31$10.36 per share12.08$49.85 per share2.51
LivaNova PLC stock logo
LIVN
LivaNova
$1.39B3.23$4.79 per share17.00$21.98 per share3.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioventus Inc. stock logo
BVS
Bioventus
$22.73M$0.7718.0315.601.829.36%28.08%9.82%N/A
Haemonetics Corporation stock logo
HAE
Haemonetics
$97.31M$2.0444.1115.701.827.12%27.55%9.65%11/5/2026 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$3.6634.1918.512.986.97%12.79%6.48%10/22/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.3824.1119.68N/A12.82%16.35%7.76%11/4/2026 (Estimated)

Latest BVS, LIVN, ITGR, and HAE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q1 2027
Haemonetics Corporation stock logo
HAE
Haemonetics
$1.08$1.14+$0.06$0.72$327.86 million$339.38 million
8/6/2026Q2 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.09$1.26+$0.17$1.93$380.50 million$390.59 million
8/5/2026Q2 2026
Bioventus Inc. stock logo
BVS
Bioventus
$0.22$0.22N/A$0.47N/A$153.21 million
8/3/2026Q2 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.38$1.60+$0.22$0.69$451.07 million$464.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
Haemonetics Corporation stock logo
HAE
Haemonetics
N/AN/AN/AN/AN/A
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioventus Inc. stock logo
BVS
Bioventus
0.83
1.69
1.17
Haemonetics Corporation stock logo
HAE
Haemonetics
1.40
3.08
1.91
Integer Holdings Corporation stock logo
ITGR
Integer
0.75
3.73
2.41
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.45
1.21

Institutional Ownership

CompanyInstitutional Ownership
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
Haemonetics Corporation stock logo
HAE
Haemonetics
99.67%
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%

Insider Ownership

CompanyInsider Ownership
Bioventus Inc. stock logo
BVS
Bioventus
33.50%
Haemonetics Corporation stock logo
HAE
Haemonetics
2.07%
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bioventus Inc. stock logo
BVS
Bioventus
1,20084.09 million55.92 millionN/A
Haemonetics Corporation stock logo
HAE
Haemonetics
3,00945.50 million44.56 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00033.99 million33.62 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.90 millionOptionable

Recent News About These Companies

LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DE
August 15 at 3:15 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-livanova-plc-livn-stake-lessened-by-bank-of-america-corp-de-2026-08-15/
LivaNova (LIVN) Q2 2026 Earnings Call Transcript
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/livanova-livn-q2-2026-earnings-153440720.html
LivaNova PLC $LIVN Shares Purchased by Quantinno Capital Management LP
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-livanova-plc-livn-shares-purchased-by-quantinno-capital-management-lp-2026-08-09/
LivaNova (NASDAQ:LIVN) Stock Price Expected to Rise, Needham & Company LLC Analyst Says
August 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30945396
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised
August 6, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2970309/livanova-q2-earnings-revenues-beat-estimates-26-outlook-raised?cid=cs-stocknewsapi-ft-analyst_blog|earnings_article-2970309
LivaNova raises guidance on Q2 beats
August 6, 2026  |  massdevice.comhttps://www.massdevice.com/livanova-q2-2026-raises-guidance-beats/
LivaNova (NASDAQ:LIVN) Releases Quarterly Earnings Results, Beats Estimates By $0.17 EPS
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/livanova-nasdaqlivn-releases-quarterly-earnings-results-beats-estimates-by-017-eps-2026-08-05/
LivaNova PLC 2026 Q2 - Results - Earnings Call Presentation
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931191-livanova-plc-2026-q2-results-earnings-call-presentation
Needham & Company LLC Forecasts Strong Price Appreciation for LivaNova (NASDAQ:LIVN) Stock
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/needham-company-llc-forecasts-strong-price-appreciation-for-livanova-nasdaqlivn-stock-2026-08-05/
LivaNova PLC (LIVN) Q2 2026 Earnings Call Transcript
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931001-livanova-plc-livn-q2-2026-earnings-call-transcript
LivaNova Q2 Earnings Call Highlights
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/livanova-q2-earnings-call-highlights-2026-08-05/
LivaNova (NASDAQ:LIVN) Shares Gap Down - Here's Why
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/livanova-nasdaqlivn-shares-gap-down-heres-why-2026-08-05/
LivaNova (LIVN) Reports Q2 Earnings: What Key Metrics Have to Say
August 5, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2968527/livanova-livn-reports-q2-earnings-what-key-metrics-have-to-say?cid=cs-stocknewsapi-ft-fundamental_analysis|nfm-2968527
LivaNova PLC (LIVN) Hits Fresh High: Is There Still Room to Run?
August 5, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2968452/livanova-plc-livn-hits-fresh-high-is-there-still-room-to-run?cid=cs-stocknewsapi-ft-52_week_high-2968452
LivaNova: Q2 Earnings Snapshot
August 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/livanova-q2-earnings-snapshot-100824885.html
LivaNova exceeds second-quarter forecasts and increases 2026 outlook
August 5, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/livanova-exceeds-second-quarter-forecasts-and-increases-2026-outlook/ar-AA29rUHP
LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates
August 5, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2968261/livanova-livn-q2-earnings-and-revenues-beat-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2968261
LivaNova (NASDAQ:LIVN) Updates FY 2026 Earnings Guidance
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/livanova-nasdaqlivn-updates-fy-2026-earnings-guidance-2026-08-05/
LivaNova (NASDAQ:LIVN) Hits New 1-Year High - Here's Why
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/livanova-nasdaqlivn-hits-new-1-year-high-heres-why-2026-08-04/
Janus Henderson Group PLC Purchases 448,703 Shares of LivaNova PLC $LIVN
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-janus-henderson-group-plc-purchases-448703-shares-of-livanova-plc-livn-2026-08-03/
Renaissance Technologies LLC Has $11.63 Million Stock Position in LivaNova PLC $LIVN
August 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-has-1163-million-stock-position-in-livanova-plc-livn-2026-08-02/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bioventus stock logo

Bioventus NASDAQ:BVS

$13.88 -0.38 (-2.66%)
As of 04:00 PM Eastern

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Haemonetics stock logo

Haemonetics NYSE:HAE

$89.98 -0.82 (-0.90%)
As of 03:58 PM Eastern

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Integer stock logo

Integer NYSE:ITGR

$125.13 -0.13 (-0.10%)
As of 03:58 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$81.48 -0.74 (-0.90%)
As of 04:00 PM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas